PlainRecalls
FDA Drug Moderate Class II Ongoing

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Reported: October 15, 2025 Initiated: September 26, 2025 #D-0008-2026

Product Description

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Reason for Recall

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Details

Units Affected
571 vials
Distribution
Nationwide within the USA.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 571 vials.
Why was this product recalled?
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2025. Severity: Moderate. Recall number: D-0008-2026.